Stockreport

Eton Pharmaceuticals: An Undervalued Small Cap With High Growth [Seeking Alpha]

Eton Pharmaceuticals, Inc.  (ETON) 
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm Check Earnings Report
PDF My DCF-based Fair Value is $28.1, representing 85% upside; optimistic scenarios suggest up to $40 per share, while downside risk is mitigated by product diversification [Read more]